Edition:
United States

Bristol-Myers Squibb Co (BMY.N)

BMY.N on New York Stock Exchange

55.69USD
2:44pm EDT
Change (% chg)

$-0.25 (-0.46%)
Prev Close
$55.95
Open
$55.96
Day's High
$55.99
Day's Low
$55.69
Volume
862,840
Avg. Vol
2,991,544
52-wk High
$77.10
52-wk Low
$46.01

Select another date:

BRIEF-Bristol-Myers enters collaboration to identify predictive biomarkers across multiple tumor types, immunotherapy agents

* Bristol-Myers Squibb enters collaboration to leverage Foundation Medicine's molecular information platform to identify predictive biomarkers across multiple tumor types and immunotherapy agents Source text for Eikon: Further company coverage:

BRIEF-Bristol-Myers Squibb receives positive CHMP opinion recommending opdivo

* Bristol-Myers Squibb receives positive chmp opinion recommending opdivo (nivolumab) for the treatment of squamous cell cancer of the head and neck in adults progressing on or after platinum-based therapy

BRIEF-Bristol-Myers' CEO Caforio's 2016 total compensation $16.9 mln

* Bristol-Myers Squibb Co - CEO Giovanni Caforio, M.D.'s 2016 total compensation was $16.9 million versus $15.6 million in 2015 - SEC filing

BRIEF-Bristol-Myers Squibb, Cytomx Therapeutics extend worldwide collaboration

* Bristol-Myers Squibb and Cytomx Therapeutics extend worldwide collaboration to discover Probody Therapeutics for the treatment of cancer and other diseases

BRIEF-Bristol-Myers Squibb appoints Thomas Lynch as Chief Scientific Officer

* Bristol-Myers Squibb appoints Dr. Thomas J. Lynch, Jr., Executive Vice President and Chief Scientific Officer

BRIEF-Bristol-Myers Squibb declared a qtrly div of $0.39 per share

* Bristol-Myers Squibb - declared a quarterly dividend of $0.39 per share on $.10 par value common stock of corporation Source text for Eikon: Further company coverage:

BRIEF-Bristol-Myers announces equity investment in GRAIL Inc

* Bristol-Myers Squibb expands focus on precision medicine with investment and planned collaboration with GRAIL on blood-based cancer screening

BRIEF-Bristol-Myers Squibb expands international immuno-oncology network

* Bristol-Myers Squibb expands international immuno-oncology network (II-ON) with addition of Columbia University Medical Center and Peter Maccallum Cancer Centre Source text for Eikon: Further company coverage:

BRIEF-Bristol-Myers Squibb prices $1.5 billion of senior notes

* Bristol-Myers Squibb prices $1.5 billion of senior notes Source text for Eikon: Further company coverage:

BRIEF-Bristol-Myers squibb files pricing term sheet

* Files pricing term sheet related to its offering of 2019 notes and 2027 notes - SEC filing Source text: (http://bit.ly/2lHhR1j) Further company coverage:

Select another date:

More From Around the Web